Zydus Wellness Limited has informed the Exchange about Investor Presentation

Listed Co AcquisitionStrategic Transactions View source PDF Explain this filing

ZYDUSWELL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+11.2%Reaction day

₹401.70

prior close

₹414.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+1.4%+9.8% vs market

Packaged Foods peers, median of 34sector+1.0%+10.3% vs sector

On the reaction day the stock moved 9.8 pts more than Nifty Smallcap 250 and 10.3 pts more than its Packaged Foods peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.5

15m

+0.3

30m

+1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+11.2+1.4+9.8+1.0+10.3

Next day

+11.5+2.0+9.5+0.2+11.3

+16.0+2.9+13.1+1.6+14.4

+21.4+2.2+19.3+2.2+19.3

+20.8+2.4+18.4+2.6+18.2

+20.0+2.6+17.4+1.0+19.1

+23.9+3.6+20.3+1.2+22.7

15d

+23.5+5.1+18.5+0.0+23.5

+14.6+2.2+12.4-3.6+18.1

+19.2+5.6+13.6-4.1+23.4

+7.5+1.6+5.9-10.1+17.7

UpDownMarket · Nifty Smallcap 250Sector · Packaged Foods peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zydus Wellness's wholly-owned UK subsidiary Alidac UK Limited has acquired 100% of Comfort Click Limited (CCL) for a cash equity value of GBP 239 million (plus agreed profit ticker adjustments). This marks Zydus Wellness's first overseas acquisition and entry into the fast-growing Vitamins, Minerals and Supplements (VMS) segment. CCL, which posted GBP 134 million in unaudited revenue for FY25 (up from GBP 85 million in FY24 and GBP 52 million in FY23, with a 57% five-year CAGR), operates three brands—WeightWorld, maxmedix, and Animigo—across the UK, Europe, and is expanding into the USA, with most revenue coming through e-commerce and D2C channels. CCL now becomes a step-down wholly-owned subsidiary of Zydus Wellness, and the deal is stated to be Cash EPS accretive. The transaction is not a related-party deal, and no government approvals were required.

Likely market impact

This is a meaningful strategic move that instantly gives Zydus Wellness a sizeable international digital consumer-healthcare platform, adding roughly GBP 134 million in annual revenue and entry into the European VMS market estimated at GBP 11 billion. Near-term, shareholders should watch integration execution and how the GBP 239 million cash outlay impacts leverage, but management's claim of Cash EPS accretion and the target's 57% growth CAGR make this a positive long-term growth catalyst for the stock.